Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Tuberculosis Drugs are used to treat tuberculosis.Tuberculosis is a chronic condition that is often undermined, though it can be fatal if left unchecked.
The report details the trend, potential and market size of Tuberculosis Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Tuberculosis Drugsmarket, defines the market attractiveness level of Tuberculosis Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Tuberculosis Drugs industry, describes the types of Tuberculosis Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Tuberculosis Drugs market and the development prospects and opportunities of Tuberculosis Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Tuberculosis Drugs market in Chapter 13.
By Player:
AstraZeneca Plc
Cipla Ltd
Pfizer Inc
Lupin Laboratories Ltd
Novartis AG
Alkem Laboratories Ltd
Cadila Pharmaceuticals
By Type:
First Line Drugs Therapy
Second Line Drugs Therapy
Combination Drugs Therapy
By End-User:
Hospital
Private clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Tuberculosis Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Tuberculosis Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Tuberculosis Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Tuberculosis Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Tuberculosis Drugs Market Analysis and Outlook to 2022
-
7.1 Global Tuberculosis Drugs Consumption (2017-2022)
-
7.2 United States Tuberculosis Drugs Consumption (2017-2022)
-
7.3 Europe Tuberculosis Drugs Consumption (2017-2022)
-
7.4 China Tuberculosis Drugs Consumption (2017-2022)
-
7.5 Japan Tuberculosis Drugs Consumption (2017-2022)
-
7.6 India Tuberculosis Drugs Consumption (2017-2022)
-
7.7 South Korea Tuberculosis Drugs Consumption (2017-2022)
8 Region and Country-wise Tuberculosis Drugs Market Analysis and Outlook to 2028
-
8.1 Global Tuberculosis Drugs Consumption Forecast (2022-2028)
-
8.2 United States Tuberculosis Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Tuberculosis Drugs Consumption Forecast (2022-2028)
-
8.4 China Tuberculosis Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Tuberculosis Drugs Consumption Forecast (2022-2028)
-
8.6 India Tuberculosis Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Tuberculosis Drugs Consumption Forecast (2022-2028)
9 Global Tuberculosis Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Tuberculosis Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global First Line Drugs Therapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Second Line Drugs Therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Combination Drugs Therapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Tuberculosis Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Private clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Tuberculosis Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Tuberculosis Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global First Line Drugs Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Second Line Drugs Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Combination Drugs Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Tuberculosis Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Private clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Tuberculosis Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Tuberculosis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Tuberculosis Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Tuberculosis Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Tuberculosis Drugs Market Competitive Analysis
-
14.1 AstraZeneca Plc
-
14.1.1 AstraZeneca Plc Company Details
-
14.1.2 AstraZeneca Plc Tuberculosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AstraZeneca Plc Tuberculosis Drugs Product and Service
-
14.2 Cipla Ltd
-
14.2.1 Cipla Ltd Company Details
-
14.2.2 Cipla Ltd Tuberculosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Cipla Ltd Tuberculosis Drugs Product and Service
-
14.3 Pfizer Inc
-
14.3.1 Pfizer Inc Company Details
-
14.3.2 Pfizer Inc Tuberculosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Inc Tuberculosis Drugs Product and Service
-
14.4 Lupin Laboratories Ltd
-
14.4.1 Lupin Laboratories Ltd Company Details
-
14.4.2 Lupin Laboratories Ltd Tuberculosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Lupin Laboratories Ltd Tuberculosis Drugs Product and Service
-
14.5 Novartis AG
-
14.5.1 Novartis AG Company Details
-
14.5.2 Novartis AG Tuberculosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis AG Tuberculosis Drugs Product and Service
-
14.6 Alkem Laboratories Ltd
-
14.6.1 Alkem Laboratories Ltd Company Details
-
14.6.2 Alkem Laboratories Ltd Tuberculosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Alkem Laboratories Ltd Tuberculosis Drugs Product and Service
-
14.7 Cadila Pharmaceuticals
-
14.7.1 Cadila Pharmaceuticals Company Details
-
14.7.2 Cadila Pharmaceuticals Tuberculosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Cadila Pharmaceuticals Tuberculosis Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Tuberculosis Drugs
-
Figure Tuberculosis Drugs Picture
-
Table Global Tuberculosis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tuberculosis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tuberculosis Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Tuberculosis Drugs Consumption by Country (2017-2022)
-
Figure United States Tuberculosis Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Tuberculosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Tuberculosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Tuberculosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Tuberculosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Tuberculosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Tuberculosis Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Tuberculosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Tuberculosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Tuberculosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Tuberculosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Tuberculosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Tuberculosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global First Line Drugs Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Second Line Drugs Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Combination Drugs Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Private clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global First Line Drugs Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Second Line Drugs Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Combination Drugs Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Private clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Tuberculosis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Tuberculosis Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Plc Tuberculosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Plc Tuberculosis Drugs Product and Service
-
Table Cipla Ltd (Foundation Year, Company Profile and etc.)
-
Table Cipla Ltd Tuberculosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Ltd Tuberculosis Drugs Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Tuberculosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Tuberculosis Drugs Product and Service
-
Table Lupin Laboratories Ltd (Foundation Year, Company Profile and etc.)
-
Table Lupin Laboratories Ltd Tuberculosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin Laboratories Ltd Tuberculosis Drugs Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Tuberculosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Tuberculosis Drugs Product and Service
-
Table Alkem Laboratories Ltd (Foundation Year, Company Profile and etc.)
-
Table Alkem Laboratories Ltd Tuberculosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alkem Laboratories Ltd Tuberculosis Drugs Product and Service
-
Table Cadila Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Cadila Pharmaceuticals Tuberculosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cadila Pharmaceuticals Tuberculosis Drugs Product and Service
-
